TROY EDWARD WILSON

Insider Reports History

Location
San Diego, CA
Signature
Teresa Bair, Attorney-in-fact for Troy E. Wilson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by TROY EDWARD WILSON:

Company Role Class Num Shares Value Price $ Report Date Ownership
Avidity Biosciences, Inc. Director Common Stock 54,425 $2,721,250 $50.00 05 Sep 2025 Direct
Kura Oncology, Inc. President and CEO, Director Common Stock 429,353 $2,207,408 $8.94 13 Nov 2025 Direct
Kura Oncology, Inc. President and CEO, Director Common Stock 300,000 $1,806,000 $6.02 13 Nov 2025 by Lorax Charitable Remainder Unitrust
Kura Oncology, Inc. President and CEO, Director Common Stock 279,194 $1,680,747 $6.02 13 Nov 2025 by One Fish Two Fish Revocable Trust
Avidity Biosciences, Inc. Director Common Stock 13,711 $655,660 $47.82 05 Sep 2025 By family trust
PUMA BIOTECHNOLOGY, INC. Director Common Stock 43,550 $148,070 $3.40 13 Jun 2025 Direct
PUMA BIOTECHNOLOGY, INC. Director Common Stock 400 $1,204 $3.01 13 Jun 2025 By Child #1
PUMA BIOTECHNOLOGY, INC. Director Common Stock 150 $451 $3.01 13 Jun 2025 By Child #2
Kura Oncology, Inc. President and CEO, Director Option to purchase common stock 1,120,000 02 Jan 2026 Direct
Avidity Biosciences, Inc. Director Stock Option (Right to Buy) 0 05 Sep 2025 Direct

Insider Reports Filed by TROY EDWARD WILSON

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KURA Kura Oncology, Inc. 02 Jan 2026 1 $0 4 President and CEO, Director 06 Jan 2026, 16:31
KURA Kura Oncology, Inc. 13 Nov 2025 1 $0 4 President and CEO, Director 14 Nov 2025, 20:00
KURA Kura Oncology, Inc. 27 Sep 2025 2 -$327,419 4 President and CEO, Director 29 Sep 2025, 19:30
KURA Kura Oncology, Inc. 08 Sep 2025 1 +$410,145 4 President & CEO, Director 09 Sep 2025, 16:28
RNA Avidity Biosciences, Inc. 05 Sep 2025 4 -$1,294,040 4 Director 09 Sep 2025, 17:53
KURA Kura Oncology, Inc. 12 Aug 2025 2 +$303,201 4 President and CEO, Director 14 Aug 2025, 16:05
RNA Avidity Biosciences, Inc. 06 Aug 2025 10 -$3,919,170 4 Director 08 Aug 2025, 17:42
PBYI PUMA BIOTECHNOLOGY, INC. 13 Jun 2025 1 -$36,720 4 Director 17 Jun 2025, 19:55
PBYI PUMA BIOTECHNOLOGY, INC. 11 Jun 2025 1 $0 4 Director 13 Jun 2025, 20:11
RNA Avidity Biosciences, Inc. 10 Jun 2025 2 $0 4 Director 12 Jun 2025, 18:26
KURA Kura Oncology, Inc. 02 Jan 2025 1 $0 4 President and CEO, Director 06 Jan 2025, 16:05
PBYI PUMA BIOTECHNOLOGY, INC. 18 Jun 2024 1 $0 4 Director 21 Jun 2024, 21:27
PBYI PUMA BIOTECHNOLOGY, INC. 13 Jun 2024 1 -$89,902 4 Director 17 Jun 2024, 19:27
RNA Avidity Biosciences, Inc. 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 18:52
KURA Kura Oncology, Inc. 24 Jan 2024 4 -$1,291,388 4 President and CEO, Director 26 Jan 2024, 17:10
KURA Kura Oncology, Inc. 02 Jan 2024 1 $0 4 President and CEO, Director 04 Jan 2024, 16:06
RNA Avidity Biosciences, Inc. 12 Dec 2023 4 $0 4 Director 14 Dec 2023, 06:50
KURA Kura Oncology, Inc. 07 Dec 2023 2 $0 4 President and CEO, Director 11 Dec 2023, 16:08
RNA Avidity Biosciences, Inc. 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 16:07
PBYI PUMA BIOTECHNOLOGY, INC. 13 Jun 2023 2 -$93,269 4 Director 15 Jun 2023, 21:14
KURA Kura Oncology, Inc. 02 Jun 2023 8 $0 4 President and CEO, Director 02 Jun 2023, 17:06
KURA Kura Oncology, Inc. 14 Jul 2022 8 $0 4 President and CEO, Director 21 Feb 2023, 16:04
PBYI PUMA BIOTECHNOLOGY, INC. 16 Jun 2022 1 -$71,971 4 Director 21 Jun 2022, 19:12
RNA Avidity Biosciences, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 20:52
PBYI PUMA BIOTECHNOLOGY, INC. 14 Jun 2022 1 $0 4 Director 16 Jun 2022, 18:49
KURA Kura Oncology, Inc. 26 Jan 2022 1 $0 4 President and CEO, Director 28 Jan 2022, 15:08
RNA Avidity Biosciences, Inc. 16 Jun 2021 1 $0 4 Director 16 Jun 2021, 20:11
PBYI PUMA BIOTECHNOLOGY, INC. 15 Jun 2021 1 $0 4 Director 17 Jun 2021, 21:11
PBYI PUMA BIOTECHNOLOGY, INC. 10 Jun 2021 1 -$292,433 4 Director 11 Jun 2021, 19:30